Jiangsu Nanfang Medical Hits Day High with 9.94% Surge in Stock Price

Jiangsu Nanfang Medical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 9.94% on June 29, 2026. The stock reached an intraday high of CNY 7.74, marking a notable achievement for the small-cap company in the Pharmaceuticals & Biotechnology sector. In terms of performance metrics, Jiangsu Nanfang Medical has shown resilience over the past year, with a 29.43% increase, outperforming the China Shanghai Composite, which recorded an 18.97% gain. Year-to-date, the stock has risen by 24.24%, again surpassing the broader market's 2.65% performance. However, the company has faced challenges, including a decline in net sales and operating profit over the past five years, with net sales decreasing at an annual rate of 10.69%. Despite these hurdles, Jiangsu Nanfang Medical's recent performance highlights its ability to navigate a competitive landscape. The company's market capitalization stands at CNY 2,242 million, reflecting its position within the small-cap segment of the market.